This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Peptides & Oligonucleotides

TIDES Europe eBook: Post-Event Report 2023

Posted by on 12 January 2024
Share this article

TIDES Europe 2023 witnessed the largest turnout in the history of the event, welcoming more than 600 attendees from across the globe. The conference took place 30 October – 1 November in Amsterdam, NL and featured new data & case studies from world-renowned speakers and companies across the entire landscape of oligonucleotides, peptides, mRNA, drug delivery and partnering strategies -- from discovery to market, with an emphasis on the European region. Thank you for making TIDES Europe 2023 the largest and most renowned event in Europe dedicated to accelerating oligonucleotide and peptide therapeutics to market.

This eBook showcases significant discussions that occurred during TIDES Europe 2023, including intracellular therapies and oligonucleotide applications, innovative flow-based peptide and protein synthesis techniques, the use of plants as biofactories for therapeutic peptides, and the potential of RNAi therapeutics. These topics feature insights from Novo Nordisk, Alnylam Pharmaceuticals, University of Queensland, and more.

We hope to see you next year at TIDES Europe 2024, 12-14 November in Hamburg, Germany.

Click to read TIDES Europe eBook: Post-Event Report 2023

Share this article